Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard of Care Versus a New Collagen and Polyethylene Glycol Haemostatic/Sealant Patch (Hemopatch) During Liver Resection. A Multicentre, Non-inferiority Prospective Randomized Study (IBERLIVER-study)

NCT03166683 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT03166683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03166683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard of Care Versus a New Collagen and Polyethylene Glycol Haemostatic/Sealant Patch (Hemopatch) During Liver Resection. A Multicentre, Non-inferiority Prospective Randomized Study (IBERLIVER-study)
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2017
Completion date
September 30, 2020
Enrollment
284 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bile leak, hemorrhage liver, liver cancer, surgery, tumor liver